should i switch to tirzepatide from semaglutide Can you Wegovy Mounjaro? Semaglutide vs Tirzepatide: Which Is

Resists DPP-4 cleavage due to the Aib-8 substitution, preserving N-terminal integrity required for receptor binding

by 2030 and 2045, that number is expected to rise to 643 million and 783 million, respectively (Monteiro-Soares and Santos, 2023

As the majority of patients with type 2 diabetes are overweight or obese this offers a potential advantage over older, established therapies, and DPP-4 inhibitors are being used in clinical practice as second-line therapy in addition to metformin in overweight and obese patients who fail to reach glycemic targets with metformin monotherapy

Sethu Reddy, president of the American Association of Clinical Endocrinology, theres a valid reason

Study served as the basis for FDA approval of liraglutide in children with type 2 diabetes